Do you have any Medicare patients with primary immunodeficiency disease who are receiving IVIG? If so, they may now enroll in the Medicare IVIG Demonstration Project to have IVIG home infusions reimbursed. This three-year demonstration project for Medicare Part B recipients with a primary immune deficiency will study the impact of paying for intravenous immunoglobulin (IVIG) home infusions. Up to 4,000 Medicare beneficiaries nationwide may enroll into the demonstration project on a first-come, first-served basis.
Please help us spread the word among your IVIG patients. Enrollment period will close September 12, 2014. However, if space is available after the initial enrollment period, CMS will accept and review applications as they come in until all slots are filled.
Read more information about the Medicare IVIG Demonstration Project on the Immune Deficiency Foundation website.